The Effect of Two Terpenoids, Ursolic Acid and Oleanolic Acid on Epidermal Permeability Barrier and Simultaneously on Dermal Functions
![]() |
Suk Won, Lim
(R&D Center of Skin Science & Cosmetics, Enprani Co.,)
Sung Won, Jung (R&D Center of Skin Science & Cosmetics, Enprani Co.,) Sung Ku, Ahn (Department of Dermatology, College of Medicine, Yonsei University) Bora, Kim (R&D Center of Skin Science & Cosmetics, Enprani Co.,) In Young, Kim (R&D Center of Skin Science & Cosmetics, Enprani Co.,) Hee Chang , Ryoo (R&D Center of Skin Science & Cosmetics, Enprani Co.,) Seung Hun, Lee (Department of Dermatology, College of Medicine, Yonsei University) |
1 | H. Ohigashi, H. Takamura, K. Koshimizu, H. Tokuda, and Y. Ito, Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation;ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L., Cancer Lett, 30(2), 143 (1986) |
2 |
K. Hanley, Y. Jiang, S. S. He, M. Friedman, P. M. Elias, D. D. Bikle, M. L. Williams, and K. R. Feingold, Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor peroxisome proliferator-activated receptor- |
3 | G. Grubauer, K. R. Feingold, and P. M. Elias, Transepidermal water loss: the signal for recovery of barrier structure and function, J. Lipid. Res., 30, 323 (1989) |
4 | S. Marquina, N. Maldonado, M. L. Garduno-Ramirez, E. Aranda, M. L. Villarreal, V. Navarro, and R. Bye, Bioactive oleanolic acid saponins and other constituents from the roots of Viguiera decurrens, Phytochemistry, 56, 93 (2001) |
5 | H. Assefa, A. Nimrod, L. Walker, and R. Sindelar, Enantioselective synthesis and complement inhibitory assay of A/B-ring partial analogues of oleanolic acid, Bioorg. Med Chem. Lett, 11, 1619 (2001) |
6 | E. M. Giner-Larza, S. Manez, M. C. Recio, R. M. Giner, J. M. Prieto, M. Cerda-Nicolas, and J. L. Rios, Oleanolic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity, Eur. J. Pharmacol., 428, 137 (2001) |
7 | S. Y. Ryu, M. H. Oak, S. K. Yoon, D. I. Cho, G. S. Yoo, T. S. Kim, and K. M. Kim, Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris, Planta Med, 66, 358 (2000) |
8 | C. Martin-Cordero, M. Reyes, M. J. Ayuso, and M. Y. Toro, Cytotoxic triterpenoids from Erica andevalensis, Z Naturforsch [C], 56, 45 (2001) |
9 | H. H. Ko, M. H. Yen, R. R. Wu, S. J. Won, and C. B. Lin, Cytotoxic isoprenylated flavans of Broussonetia kazinoki, J. Nat. Prod., 62, 164 (1999) |
10 | L. Landmann, Epidermal permeability barrier: transformation of lamella-granule disks into intercellular sheets by membrane-fusion process, a freeze-fracture study, J. Invest. Dermatol., 87, 202 (1986) DOI ScienceOn |
11 |
H. Matsuura, H. Adachi, R. C. Smart, X. Xu, J. Arata, and A. M. Jetten, Correlation between expression of peroxisome proliferator-activated receptor |
12 | S. A. Kliwer, K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans, Convergence of 9-cisretinoid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors, Nature, 358, 771 (1992) |
13 | H. E. Xu, M. H. Lambert, V. G. Montana, K. D. Plunket, L. B. Moore, J. L. Collins, J. A. Oplinger, S. A. Kliewer, R. T. Jr Gampe, D. D. Mckee, J. T. Moore, and T. M. Willson, Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors, Proc. Natl. Acad. Sci. USA., 94, 4318 (1997) |
14 | M. Gottlicher, E. Widmark, Q. Li, and J. A. Gustafsson, Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor, Proc. Natl. Acad. Sci. USA, 15, 89, 4653 (1992) |
15 | Y. Nishimori, H. Tsuruoka, and K. Matsumoto, A new approach for the improvement of photoaged skin through collagen fiber bundle reconstruction mechanism, In: Proceedings of the 20th International Federation of Societies of Cosmetic. Chemists: Congress, Section O009, 1 |
16 | G. J. Gendimenico, and J. A. Mezick, Pharmacological effects of retinoids on skin cells, Skin Pharmacol., 6, 24 (1993) |
17 | M. Gottlicher, A. Demoz, D. Svensson, P. Tollet, R. K. Berge, and J. A. Gustafsson, Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor, Biochem Pharmacol., 46, 2177 (1993) |
18 | M. E. Alvarez, A. O. Maria, and J. R. Saad, Diuretic activity of Fabiana patagonica in rats, Phytother Res., 16, 71 (2002) |
19 | N. Y. Schurer, and P. M. Elias, The biochemistry and function of stratum corneum lipids. In: Elias P (ed.) Skin Lipids, Advances in Lipid Res San Diego: Academic Press, 24, 27 (1991) |
20 | S. K. Ahn, S. M. Hwang, S. J. Jiang, E. H. Choi, and S. H. Lee, The changes of epidermal calcium gradient and transitional cells after prolonged occlusion following tape stripping in murine epidermis, J. Invest. Dermatol., 113, 189 (1999) |
21 | R. Mukherjee, J. Strasser, L. Jow, P. Hoener, J. R. Jr Paterniti, and R. A. Heyman, RXR agonists activate PPAR-inducible genes, lower triglycerides, and raise HDL levels in vivo, Arterioscler Thromb Vasc Biol, 18, 272 (1998) |
22 | K. Schoonjans, B. Staels, and J. Auwerx, Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression, J. Lipid. Res., 37, 907 (1996) |
23 | S. B. Mahto, S. K. Sarkar, and G. Poddar, phytochemistry, 7, 3037 (1988) |
24 | K. Yu, W. Bayona, C. B. Kallen, H. P. Harding, C. P. Ravera, G. MaMahon, M. Brown, and M. A. Lazar, Differential activation of peroxisome proliferator-activated receptors by eicosanoids, J. Biol. Chem, 270, 23975 (1995) |
25 | H. Q. Tang, J. Hu, L. Yang, and R. X. Tan, Terpenoids and flavonoids from Artemisia species, Planta Med, 66, 391 (2000) |
26 | H. Ismaili, S. Tortora, S. Sosa, S. Fkih-Tetouani, A. llidrissi, R. Della Loggia, A. Tubaro, and R. Aquino, Topical anti-inflammatory activity of Thymus willdenowii, J. Pharm. Pharmacol., 53, 1645 (2001) |
27 | Y. Muto, M. Ninomiya, and H. Fujiki, Present status research on cancer chemoprevention in Japan, Japanese J. Clinical Oncology, 20, 219 (1990) |
28 | E. Fuchs, Epidermal differentiation: the bare essentials, J. Cell. BioI., 111, 2807 (1990) |
29 | K. Tsukahara, S. Moriwaki, T. Fujimura, and Y. Takema, Inhibitory effect of an extract of Sangui-sorba officinalis L. on ultraviolet-B-induced photo-damage of rat skin, Biol. Pharm Bull., 24, 998 (2001) |
30 | P. M. Steinert, The complexity and redundancy of epithelial barrier function, J Cell Biol, 151, F5 (2000) DOI |
31 | D. Both, K. Goodzova, D. B. Yarosh, and D. A. Brown, Liposome-encapsulated ursolic acid increased ceramides and collagen in human skin cells, Arch Dermatol. Res., 293, 569 (2002) |
32 | C. Ma, N. Nakamura, M. Hattori, H. Kakuda, J. Qiao, and H. Yu, Inhibitory effects on HIV-l protease of constituents from the wood of Xanthoceras sorbifolia, J. Nat. Prod, 63, 238 (2000) |
33 | M. Y. Rios, A. Gonzalez-Morales, and M. L. Villarreal, Sterols, triterpenes and biflavonoids of Viburnum jucundum and cytotoxic activity of ursolic acid, Planta. Med, 67, 683 (2001) |
34 | H. E. Xu, M. H. Lambert, V. G. Montana, D. J. Parks, S. G. Blanchard, P. J. Brown, D. D. Sternbach, J. M. Lehmann, G. B. Wisely, T. M. Willson, S. A. Kliewer, and M. V. Milburn, Molecular recognition of fatty acids by peroxisome proliferator-activated receptors, Mol. Cell, 3, 397 (1999) |
35 | C. E. M. Griffiths and J. J. Voorhees, Topical retinoic acid for photoaging: clinical response and underlying mechanisms, Skin. Pharmacol., 6, 70 (1993) |
36 | P. M. Elias and G. K. Menon, Structural and lipid biochemical correlates of the epidermal permeability barrier, Adv Lipid Res., 24, 1 (1991) |
37 | D. J. Mangelsdorf and R. M. Evans, The RXR heterodimers and orphan receptors, Cell, 83, 841 (1995) |
38 | J. Pinnagoda, R. A. Tupker, T. Agner, and J. Serup, Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis, Contact Dermatitis. 22, 164 (1990) |
39 | G. Imokawa, S. Akasaki, A. Kawamata, and M. Kawai, Water-retaining function in the stratum corneum and its recovery properties by synthetic pseudoceramide, J. Soc. Cosmet. Chem, 40, 273 (1989) |
40 | M. River, I. Safonova, P. Lebrun, C. E. Griffiths, G. Ailhaud, and S. Michel, Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of keratinocytes, J. Invest. Dermatol, 111, 1116 (1998) |
41 | Y. Kashiwada, T. Nagao, A. Hashimoto, Y. Ikeshiro, H. Okabe, L. M. Cosentine, and K. H. Lee, Anti-AIDS agents 38. Anti-HIV activity of 3-Oacyl ursolic acid derivatives, J. Nat. Prod, 63, 1619 (2000) |
42 | F. Hollosy, M. Idei, G. Csorba, E. Szabo, G. Bokonyi, A. Seprodi, G. Meszaros, B. Szende, and G. Keri, Activation of caspase-3 protease during the process of ursolic acid and its derivative-induced apoptosis, Anticancer. Res., 21, 3485 (2001) |
43 | S. A. Kliewer, S. S. Sundseth, and S. A. Jones et al., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors, Proc. Natl. Acad. Sci. USA, 94, 4318 (1997) |
44 | C. Y. Choi, H. J. You, and H. G. Jeong, Nitric oxide and tumor necrosis factor-a production by oleanolic acid via NF-kB activation in macrophages, Biochem. Bioptiys. Res. Commun, 288, 49 (2001) |
45 | M. Ponec, A. Weerheim, and J. Kempenaar, Retinoids and lipid changes in keratinocytes, Methods. Enzymol., 190:30 |
46 | M. A. Lampe, M. L. Williams, and P. M. Elias, Human epidermal lipids: characterization and modulations during differentiation, J Lipid Res., 24, 131 (1983) |
47 | H. Keller, C. Dreyer, J. Medin, A. Mahfoudi, K. Ozato, and W. Wahli, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers, Proc. Natl. Acad Sci., 90, 2160 (1993) |
48 | H. Tokuda, H. Ohigashi, K. Koshimizu, and Y. Ito, Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate, Cancer Letters, 33, 279 (1986) |
49 | F. Hollosy, G. Meszaros, G. Bokonyi, M. Idei, A. Seprodi, B. Szende, and G. Keri, Cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells, Anticancer Res., 20, 4563 (2000) |
50 |
K. Hanley, Y. Jiang, D. Crumrine, N. M. Bass, R. Appel, P. M. Elias, M. L. Williams, and K. R. Feingold, Activators of the nuclear hormone receptors PPAR |
51 | D. Baricevic, S. Sosa, Della Loggia R, A. Tubaro, B. Simonovska, A. Krasna, and A. Zupancic, Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid, J. Ethnopharmacol, 75, 125 (2001) |
52 | A. E. K. James, D. W. Timothy, and L. Gorden, Inhibition of human leucocyte and porcine pancreatic elastase by homologues of bovine pancreatic truosin inhibitors, Biochemistry, 35, 9090 (1996) |
53 | F. Lauthier, L. Taillet, P. Trouillas, C. Delage, and A. Simon, Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells, Anticancer Drugs, 11, 737 (2000) |
54 | S. Kersten, B. Desvergne, and W. Wahli, Roles of PPAR in health and disease, Nature, 405, 421 (2000) |
55 |
L. G. Komuves, K. Hanley, M. Q. Man, P. M. Elias, M. L. Williams, and K. R. Feingold, Keratinocytes differentiation in hyperproliferative epidermis: topical application of PPAR |
56 | T. K. Yim, W. K. Wu, W. F. Pak, and K. M. Ko, Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice, Phytother. Res., 15, 589 (2001) |
57 | K. Hanley, L. G. Komuves, N. B. Bass, S. S. He, Y. Jiang, D. Crumrine, R. Appel, M. Friedman, J. Bettencourt, K. Min, P. M. Elias, M. L. Williams, and K. R. Feingold, Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators, J. Invest. Dermatol., 113, 788 (1999) |
58 | E. H. Choi, S. K. Ahn, and S. H. Lee, The changes of stratum corneum interstices and calcium distribution of follicular epithelium of experimentally induced comedones (EIC) by oleic acid, Exp Dermatol. 6, 29 (1997) |
59 | J. Rogers, C. Harding, A. Mayo, J. Banks, and A. Rawlings, Stratum corneum lipids: the effects of ageing and the seasons, Arch Dermatol. Res., 288, 765 (1996) |
60 | J. L. Bolognia, I. M. Braverman, M. E. Rousseau and P. M. Sarrel, Skin changes in menopause, Maturitas, 11, 295 (1989) |
61 | J Li, L. Z. Xu, and W. P. Zhu, Effects of ursolic acid and oleanolic acid on Jurkat lymphoma cell line in vitro, Zhongguo Aizheng Zazhi, 9, 395 (1999) |
62 | T. S. Jeong, E. I. Hwang, H. B. Lee, E. S. Lee, Y. K. Kim, B. S. Min, K. H. Bae, S. H. Bok, and S. C. Kim, Chitin synthase II inhibitory activity of ursolic acid, isolated from Crataegus pinnatifida, Planta Med, 65, 261 (1999) |
63 | P. G. Latha and K. R. Panikkar, Modulatory effects of ixora coccinea flower on cyclophosphamide-induced toxicity in mice, Phytother. Res; 13, 517 (1999) DOI ScienceOn |
64 | D. B. Yarosh, D. Both, and D. Brown, Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin, Horm Res, 54, 318 (2000) |
65 | P. W. Wertz and D. T. Downing, Epidermal lipids. In: L. A. Golsmith (ed.) Physiology, Biochemistry and Molecular Biology of the skin New York: Oxford University Press, 205 (1991) |
66 | M. River, I. Casiel, I. Safonova, G. Ailhaud, and S. Michel, Peroxisome proliferator activated receptorenhances lipid metabolism in a skin equivalent model, J. Invest. Dermatol, 114, 681 (2000) |
67 |
L. G. Komuves, K. Hanley, A. M. Lefebver, M. Q. man, D. C. Ng, D. D. Bikle, M. L. Williams, P. M. Elias, J. Auwerx, and K. R. Feingold, Stimulation of PPAR |
68 | H. G. Jeong, Inhibition of cytochrome P450 2E1 expression by oleanolic acid hepatoprotective effects against carbon tetrachloride-induced hepatic injury, Toxicol. Lett., 105, 215 (1999) |
69 | Y. Wang, W. W. Porter, N. Suh, T. Honda, G. W. Gribble, L. M. Lessenitzer, K. D. Plunket, D. J. Mangelsdorf, S. G. Blanchard, T. M. Willson, and M. B. Sporn, A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor g, Mol Endocrinol, 14, 1550 (2000) |
70 | D. T. Downing, Lipid and protein structures in the permeability barrier of mammalian epidermis, J Lipid Res., 33, 301 (1992) |
71 | J. Liu, Pharmacology of oleanolic acid and ursolic acid, J. Ethnopharmacol, 49, 57 (1995) |
72 | J. Uitto and E. F. Bernstein, Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis, J. Invest. Dermaiol., 3, 41 (1998) |
73 | B. Saraswat, P. K. Visen, and D. P. Agarwal, Ursolic acid isolated from Eucalyptus tereticornis protects against ethanol toxicity in isolated rat hepatocytes, Phytother. Res; 14, 163 (2000) |
74 | M. T. Huang, C. T. Ho, Z. Y. Wang, T. Ferraro, Y. R. Lou, K. Stauber, W. Ma, and C. Gecrgiadis, Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid, Cancer. Res., 154(3), 701 (1994) |
75 | K. Subbaramaiah, P. Michaluart, M. B. Sporn, and A. J. Dannenberg, Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells, Cancer Res., 60, 2399 (2000) |
76 | H. J. Cha, M. T. Park, H. Y. Chung, N. D. Kim, H. Sato, M. Seiki, and K. W. Kim, Ursolic acid induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells, Oncogene, 16, 771 (1998) |
![]() |